Quantifying Diversity and Representation in Pivotal Trials Leading to Marketing Authorization in Europe.
Zachary P SmithEmily BottoKenneth GetzPublished in: Therapeutic innovation & regulatory science (2022)
Guidelines encouraging the reporting of patient demographic data are insufficient and availability of the data is problematic. The available data suggest that under-representation in pivotal trials is widespread.